Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study

Amminger, G. Paul, Schäfer, Miriam R., Schlögelhofer, Monika, Klier, Claudia M., McGorry, Patrick D.·2015·Nature Communications

Cited by (186)

Items 101–186 of 186

  1. Associations of fatty acids with cognition, psychopathology, and brain-derived neurotrophic factor levels in patients with first-episode schizophrenia and related disorders treated with paliperidone extended release
    Young‐Chul Chung, Yin Cui, Tomiki Sumiyoshi, Min‐Gul Kim, Keon‐Hak Lee · 2017 · Journal of Psychopharmacology
  2. Sex influences in the preventive effects of peripubertal supplementation with N-3 polyunsaturated fatty acids in mice exposed to the two-hit model of schizophrenia
    Ayane Edwiges Moura da Costa, Nayana Soares Gomes, Carlos Venício Jatai Gadelha Filho, Maria Gabrielle Oliveira e Silva Linhares, Roberta Oliveira da Costa, Adriano José Maia Chaves Filho, R.C. Cordeiro, Germana Silva Vasconcelos, Francisco Eliclécio Rodrigues da Silva, Tatiane da Silva Araújo et al. · 2021 · European Journal of Pharmacology
  3. Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis
    Subash Raj Susai, Colm Healy, David Mongan, Meike Heurich, Jonah F. Byrne, Mary D Cannon, Gerard Cagney, Kieran J. Wynne, Connie Markulev, Miriam R. Schäfer et al. · 2022 · Translational Psychiatry
  4. The role of brain n-3 fatty acids-GPR40/FFAR1 signaling in pain
    Kazuo Nakamoto, Shogo Tokuyama · 2018 · Folia Pharmacologica Japonica
  5. Omega-3 and Omega-6 fatty acids and risk of psychotic outcomes in the ALSPAC birth cohort
    Andrew David Thompson, Hannah J Jones, Jon Heron, Joseph R. Hibbeln, Sarah A. Sullivan, Stanley Zammit · 2020 · Schizophrenia Research
  6. Network Meta-Analysis Indicates Superior Effects of Omega-3 Polyunsaturated Fatty Acids in Preventing the Transition to Psychosis in Individuals at Clinical High-Risk
    Chengfeng Chen, Yongyan Deng, Yuling Li, Meiting Zhang, Tong Yu, Kun Xie, Wuyou Bao, Peiying Li, Ling Sun, Tianhong Zhang et al. · 2024 · The International Journal of Neuropsychopharmacology
  7. Preventing Schizophrenia and Severe Mental Illness
    Jordan DeVylder · 2015 · Research on Social Work Practice
  8. Efficacy of Polyunsaturated Fatty Acids (PUFAs) on Impulsive Behaviours and Aggressiveness in Psychiatric Disorders
    Silvio Bellino, Paola Bozzatello, Cristina Badino, Emanuela Mantelli, Paola Rocca · 2021 · International Journal of Molecular Sciences
  9. Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator
    Silvia Hoirisch-Clapauch, Antônio Egídio Nardi · 2015 · International Journal of Molecular Sciences
  10. Omega-3 fatty acids in cause, prevention and management of violence in schizophrenia: Conceptualization and application
    Wen‐Chen Ouyang, Gwo‐Ching Sun, Mei‐Chi Hsu · 2019 · Aggression and Violent Behavior
  11. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial
    Subash Raj Susai, David Mongan, Colm Healy, Mary D Cannon, Barnaby Nelson, Connie Markulev, Miriam R. Schäfer, Maximus Berger, Nilufar Mossaheb, Monika Schlögelhofer et al. · 2021 · Brain Behavior and Immunity
  12. Higher Dietary Inflammation in Patients with Schizophrenia: A Case-Control Study in Korea
    Hee Shon Yun, Soo Jin Yang, Sung‐Wan Kim · 2021 · Nutrients
  13. Scale-Up to Pilot of a Non-Axenic Culture of Thraustochytrids Using Digestate from Methanization as Nitrogen Source
    Denis de la Broise, Mariana Ventura, Luc Chauchat, Maurean Guerreiro, Teo Michez, Thibaud Vinet, Nicolas Gautron, Fabienne Le Grand, Antoine Bideau, Nelly Le Goïc et al. · 2022 · Marine Drugs
  14. Predictors of longer-term outcome in the Vienna omega-3 high-risk study
    Nilufar Mossaheb, Miriam R. Schäfer, Monika Schlögelhofer, Claudia M. Klier, Stefan Smesny, Patrick D. McGorry, Maximus Berger, G. Paul Amminger · 2017 · Schizophrenia Research
  15. Nutrition and schizophrenia: associations worthy of continued revaluation
    Mimi Tang, Tingyu Zhao, Ting Chia Liu, Ruili Dang, Hualin Cai, Ying Wang · 2023 · Nutritional Neuroscience
  16. The therapeutic effect of omega-3 polyunsaturated fatty acids on symptom severity of psychosis: A systematic review and meta-analysis
    Alison T. Rossier, Brian P. Hallahan · 2024 · European Psychiatry
  17. ω-3 Polyunsaturated Fatty Acids to Prevent Psychosis
    John Michael Kane, Christoph Ulrich Correll · 2016 · JAMA Psychiatry
  18. A Systematic Review of Effectiveness of Omega-3 Fatty Acid Supplementation on Symptoms, Social Functions, and Neurobiological Variables in Schizophrenia
    Mei‐Chi Hsu, Wen‐Chen Ouyang · 2021 · Biological Research For Nursing
  19. Lipides membranaires dans la schizophrénie et la psychose débutante : de potentiels biomarqueurs et pistes thérapeutiques ?
    Ariel Frajerman, Oussama Kébir, Boris Chaumette, Cédric Tessier, Antonin Lamazière, Philippe Nuss, Marie‐Odile Krebs · 2020 · L Encéphale
  20. FFAR1/GPR40 Contributes to the Regulation of Striatal Monoamine Releases and Facilitation of Cocaine-Induced Locomotor Activity in Mice
    Yuko Sadamura, Shanta Thapa, Ryota Mizunuma, Yuki Kambe, Akira Hirasawa, Kazuo Nakamoto, Shogo Tokuyama, Koji Yoshimoto, Kazunori Arita, Atsuro Miyata et al. · 2021 · Frontiers in Pharmacology
  21. More assortative mating in US compared to European parents and spouses of patients with bipolar disorder: implications for psychiatric illness in the offspring
    Robert M. Post, Lori L. Altshuler, Ralph Kupka, Susan L. McElroy, Mark A. Frye, Michael Rowe, Heinz Grunze, Trisha M Suppes, Paul E. Keck, Willem A. Nolen · 2018 · European Archives of Psychiatry and Clinical Neuroscience
  22. Ultralong TE In Vivo 1H MR Spectroscopy of Omega‐3 Fatty Acids in Subcutaneous Adipose Tissue at 7 T
    Martin Gajdošík, Lukas Hingerl, Antonín Škoch, Angelika Freudenthaler, Patrik Krumpolec, Jozef Ukropec, Barbara Ukropcová, Petr Šedivý, Milan Hájek, Bianca Karla Itariu et al. · 2018 · Journal of Magnetic Resonance Imaging
  23. Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCAN
    Margot I. E. Slot, Maria Fernanda Urquijo-Castro, Inge Winter-van Rossum, Hendrika H. van Hell, Dominic Dwyer, Paola Dazzan, Arija Maat, Lieuwe de Haan, Benedicto Crespo‐Facorro, Birte Yding Glenthoj et al. · 2024 · Schizophrenia
  24. Analysis of the Thickness of the Outer Retinal Layer Using Optical Coherence Tomography – A Predictor of Visual Acuity in Schizophrenia
    Erman Bozali, Duygu Yalınbaş · 2022 · Klinische Monatsblätter für Augenheilkunde
  25. Neurophysiological differences between patients clinically at high risk for schizophrenia and neurotypical controls – first steps in development of a biomarker
    Frank Hopkins Duffy, Eugene J. D’Angelo, Alexander Rotenberg, Joseph Gonzalez–Heydrich · 2015 · BMC Medicine
  26. Increased PLA2 activity in individuals at ultra-high risk for psychosis
    Leda Leme Talib, Alana C. Costa, Helena Passarelli Giroud Joaquim, Cícero A. C. Pereira, Martinus Theodorus van de Bilt, Alexandre Andrade Loch, Wagner F. Gattaz · 2021 · European Archives of Psychiatry and Clinical Neuroscience
  27. A Case of Attenuated Psychosis Syndrome: A Broad Differential Diagnosis Requires Broad-Spectrum Treatment
    Kristin S. Cadenhead, Heline Mirzakhanian · 2016 · American Journal of Psychiatry
  28. Omega-3 Supplementation Reduces Schizotypal Personality in Children: A Randomized Controlled Trial
    Adrian Raine, Ruben C. Gur, Raquel E. Gur, Therese S. Richmond, Joseph R. Hibbeln, Jianghong Liu · 2024 · Schizophrenia Bulletin
  29. Nutrition, Exercise, and Stress Management for Treatment and Prevention of Psychiatric Disorders. A Narrative Review Psychoneuroendocrineimmunology-Based
    F. Bottaccioli, A. Bottaccioli, E. Marzola, P. Longo, A. Minelli, G. Abbate-Daga · 2021 · Endocrines
  30. Exploring the key factors of schizophrenia relapse by integrating LC-MS/1H NMR metabolomics and weighted correlation network analysis
    Song Lin, Ping Li, Jinglei Qin, Qi Liu, Jinling Zhang, Nana Meng, Cuicui Jia, Kunjie Zhu, Dan Lv, Lei Sun et al. · 2023 · Clinica Chimica Acta
  31. Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?
    Ahmed Naguy · 2017 · Journal of Dietary Supplements
  32. Effects of omega-3 polyunsaturated fatty acid supplementation on cognitive functioning in youth at ultra-high risk for psychosis: secondary analysis of the NEURAPRO randomised controlled trial
    Nicholas Cheng, Alison McLaverty, Barnaby Nelson, Connie Markulev, Miriam R. Schäfer, Maximus Berger, Nilufar Mossaheb, Monika Schlögelhofer, Stefan Smesny, Ian Bernard Hickie et al. · 2022 · BJPsych Open
  33. Higher stress response and altered quality of life in schizophrenia patients with low membrane levels of docosahexaenoic acid
    Vladimir Adrien, Nicolas Bosc, Hugo Fumat, Cédric Tessier, Florian Ferreri, Stéphane Mouchabac, David C. Tareste, Philippe Nuss · 2023 · Frontiers in Psychiatry
  34. Shared genetic basis informs the roles of polyunsaturated fatty acids in brain disorders
    Huifang Xu, Yitang Sun, Michael Francis, Claire F. Cheng, Nitya T.R. Modulla, James Thomas Brenna, Charleston W. K. Chiang, Kaixiong Ye · 2023 · medRxiv
  35. Effect of n-3 polyunsaturated fatty acids on the treatment of schizophrenia: an updated systematic review and meta-analysis
    Chia‐Yu Lin, Jen‐Ai Lee, Tzu‐Rong Peng, Pei-Yun Tsai, Pin-Hao Huang, Ming‐Chia Lee, Shih Ming Chen · 2025 · BMC Psychiatry
  36. Getting in Early: Early Intervention Services for Psychosis
    Jesse Gates, Eoin J. Killackey · 2019 · Elsevier eBooks
  37. A Versatile and Stable Mixture of Fish Oil and Resveratrol in a Powder Formulation
    M. Santaniello · 2016 · Nutrition and Food Technology Open Access
  38. Omega-3 Polyunsaturated Fatty Acids and Antioxidants for the Treatment of Schizophrenia: A Role for Magnetic Resonance Imaging
    Rosarito Clari, Robert K. McNamara, Philip R. Szeszko · 2020 · Springer eBooks
  39. Cerebral ischemia-induced genes are increased in acute schizophrenia: an opportunity for clinical translation of genomic research findings
    Hans W. Moises, Moritz Hess, Harald Binder · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Nutritional Management of Schizophrenia: Gut-Brain Axis Mechanisms and Dietary Interventions
    Omid Vakili, Mahsa Motamed, Motahareh Taghizadeh, Seyyed Hossein Khatami · 2026 · Molecular Neurobiology
  41. The Importance of Psychoneuroimmunology for Social Workers
    Jill Leslie Littrell · 2018 · Families in Society The Journal of Contemporary Social Services
  42. Attenuated Psychosis Syndrome
    Zarina Rovane Bilgrami, Natasha T. Kostek, Ian T. Kim, Rebecca Kraut, Jong Kyoung Kim, Cheryl Mary Corcoran · 2020 · Springer eBooks
  43. II ruolo degli omega-3 nel paziente pluripatologico complesso: dalle evidenze alla pratica clinica in Medicina Interna
    Guest Editors P. Gnerre, M. Campanini, Andrea Fontanella, Roberto Nardi · 2015 · Italian Journal of Medicine
  44. First Episode Psychosis in Patients Aged 18 to 30 Admitted Involuntarily: Characteristics and Risk Factors for Functional Non-Remission
    Maria A. El Helou, Matthieu Hein, Beni-Champion Cimpaye, Benjamin Wacquier, Anais Mungo · 2025 · Brain Sciences
  45. Lifelong dietary Omega-3, -6, and -9 ratios shape adult behavior and response to adolescent THC exposure in rats
    Ariel Frajerman, Aude Marzo, Boris Chaumette, Thérèse M. Jay, Fanny Demars, Antonin Lamazière, Oussama Kébir, Marie‐Odile Krebs, Gwenaëlle Le Pen · 2025 · Pharmacology Biochemistry and Behavior
  46. Widespread but moderate genetic overlap between circulating polyunsaturated fatty acids and brain disorders
    Huifang Xu, Yitang Sun, Michael Francis, Claire F. Cheng, Nitya T.R. Modulla, James Thomas Brenna, Charleston W. K. Chiang, Kaixiong Ye · 2025 · Journal of Lipid Research
  47. Stati mentali a rischio di psicosi: identificazione e strategie attuali di trattamento [translation of “At-risk mental state for psychosis: identification and current treatment approaches” by Dr. Giulia Rioli]
    Andrew David Thompson, Steven Marwaha, Matthew R. Broome · 2016 · BJPsych Advances
  48. Can Kampo and Dietary Supplement Address Unmet Need? – A Commentary on Tatsumi et al. and Hoffmann et al.
    Takashi Tsuboi · 2019 · Pharmacopsychiatry
  49. Früherkennung und Frühbehandlung von Menschen mit erhöhtem Psychoserisiko
    Hendrik Müller, Andreas Bechdolf · 2020 · Springer eBooks
  50. Effectiveness of Immunotherapies for Psychotic Disorders
    Rachel Upthegrove, J.F.W. Deakin · 2021 · Cambridge University Press eBooks
  51. The Role of Psychopharmacology in Mental Health Prevention
    Christopher Lemon, Andrew David Thompson · 2022 · Springer eBooks
  52. Neuroprotection induced by omega-3 polyunsaturated fatty acids: focus on neuropsychiatric disorders
    Melissa Bujtor, Kuan‐Pin Su, Alessandra Borsini · 2024 · Elsevier eBooks
  53. Omega-3 fatty acids in schizophrenia Part II: Clinical applications
    Joanna Róg, Ewa Stelmach, Bożena Śpila, Jacek Gajewski, Dariusz Juchnowicz, Aleksandra Korzeniowska, Joanna Tomaka, Hanna Karakuła‐Juchnowicz · 2016 · Current Problems of Psychiatry
  54. Pharmacological intervention for people at risk of psychotic disorder
    Eva Burkhardt, Karolina Leopold, Andreas Bechdolf · 2020 · Elsevier eBooks
  55. P.115 Membrane lipids in early phases of psychosis: potential biomarkers for a personalised medicine?
    Ariel Frajerman, Boris Chaumette, Antonin Lamazière, Cédric Tessier, Philippe Nuss, Marie‐Odile Krebs, Oussama Kébir · 2021 · European Neuropsychopharmacology
  56. INFANCIA Y ADOLESCENCIA: UNA VENTANA ABIERTA PARA LA PREVENCIÓN DE TRASTORNOS MENTALES CHILDHOOD AND ADOLESCENCE: AN OPEN WINDOW FOR THE PREVENTION OF MENTAL DISORDERS
    Celso Arango, Elena Serrano-Drozdowskyj · 2016
  57. Pro und Kontra zu Antipsychotika bei „Prodromalstadien der Schizophrenie“
    Stefan Weinmann, Volkmar Aderhold · 2017 · Der Nervenarzt
  58. Early Intervention in Psychosis
    Paolo Fusar‐Poli, Giulia Spada · 2017
  59. Identification and management of high‐risk psychosis in children and adolescents
    Lorena E. Reyna, Jeffrey Hunt · 2018 · The Brown University Child and Adolescent Behavior Letter
  60. Supplemental Use of Complementary Alternative Medicine for the Treatment of Schizophrenia
    Steven J. Gabriel, Kristen M. Ward, Vicki L. Ellingrod · 2018 · Psychiatric Annals
  61. A Survey Towards Holistic Management of Schizophrenia
    Pronab Ganguly, Ahmed A. Moustafa · 2018 · Journal of Psychology Research
  62. PORTFÖY YÖNETİM SÖZLEŞMESİ VE HUKUKİ NİTELİĞİ
    İlke Aytekin Gemici · 2008
  63. Novel Biological Treatment Strategies
    G. Paul Amminger, Maximus Berger · 2019 · Cambridge University Press eBooks
  64. Attenuated Psychosis Syndromes Among Australian Youth and Young Adults: Early Identification and Intervention
    Barnaby Nelson, Patrick D. McGorry · 2019 · Springer eBooks
  65. Maternal Immune Activation Alters Behavior of Adult Offspring: Sex-Dependent Impairment and Attenuation by Glycan
    Megan A. Arnold · 2020
  66. Déficits motivationnels et acides gras polyinsaturés
    Fabien Ducrocq, Pierre Trifilieff · 2021 · médecine/sciences
  67. Guía fácil de Tai Chi
    Claire Hooton · 1997 · Dialnet (Universidad de la Rioja)
  68. Bioactive and Inflammatory Markers in Emerging Psychotic Disorders
    Gregor Emanuel Berger · 2019 · Cambridge University Press eBooks
  69. Food and mood
    Galen Ives · 2018 · Clinical Psychology Forum
  70. Complementary/Integrative Medicine Treatment and Prevention of Youth Psychosis
    Vinod S. Bhatara, Jeremy Daniel, Carol Whitman, Tamara Vik, Bettina Bernstein, Deborah Risher Simkin · 2023 · Child and Adolescent Psychiatric Clinics of North America
  71. Psychosis in Sports
    Patrick A. Ho, Todd Stull, Douglas L. Noordsy · 2023 · Springer eBooks
  72. The involvement of brain fatty acid-GPR40/FFAR1 signaling in the stress-induced chronic pain
    Kazuo Nakamoto, Shogo Tokuyama · 2023 · Folia Pharmacologica Japonica
  73. Relevance of Diet in Schizophrenia: Focusing on Prenatal Nutritional Deficiency, Obesity, Oxidative Stress and Inflammation
    Amalia Vasile, Viorica Rarinca, Vasile Burlui, Gabriela Halitchi, Alin Stelian Ciobica, Ana-Maria Sîngeap, Romeo Dobrin, Ecaterina Burlui, Anca Victorita Trifan · 2024 · Preprints.org
  74. Oméga-3 et psychiatrie : que dit la littérature ?
    Ariel Frajerman · 2024 · Annales Médico-psychologiques revue psychiatrique
  75. Over-the-Counter Medications and Nutritional Supplements in Child Psychiatry
    Robert L. Hendren, Madeline I. Spiess, Felicia Widjaja · 2024 · Springer eBooks
  76. Tracing the Trajectory: Polyunsaturated Fatty Acids and Early Adult Psychosis
    Ying He, Linlin Zhao, Xiaogang Chen · 2024 · Biological Psychiatry
  77. Early Intervention in Psychosis: A Brief Narrative Review
    Vivek Agarwal, Arundhati Gairola · 2024 · Journal of Indian Association for Child and Adolescent Mental Health
  78. The Role of the Immune System in Creating Depression, Post-traumatic-Stress-Disorder, and Psychosis
    Jill Leslie Littrell · 2024 · Integrated science
  79. Distribution of red blood cell fatty acids in stable patients with a schizophrenia spectrum disorder and healthy controls
    Gwendolyn Schoemaker, Roel J. T. Mocking, Suzanne Medema, Maarten W.J. Koeter, Lieuwe de Haan, Nico J.M. van Beveren · 2025 · Schizophrenia Research
  80. THE ROLE OF DIETARY PATTERNS AND NUTRIENTS IN SCHIZOPHRENIA: A LITERATURE REVIEW
    Natalia Kraciuk, Alicja Bury, Karol Bartecki, Małgorzata Piekarska, Aleksandra Maciejczyk, Katarzyna Krupa, Julia Błoniecka, Kacper Jankowski, Anna Daniel · 2025 · International Journal of Innovative Technologies in Social Science
  81. Erythrocyte membrane nervonic acid in drug-naive first-episode psychosis and chronic medicated schizophrenia: Implication for impaired myelination and prognosis
    Mohammad M. Khan · 2025 · World Journal of Psychiatry
  82. Vulnérabilité du réseau neuronal du noyau accumbens à la déficience développementale en acides gras polyinsaturés n-3 : conséquences sur le système de récompense et de motivation
    Fabien Ducrocq · 2018 · theses.fr (ABES)
  83. Le rôle respectif des différents populations de neurones épineux moyens du noyau accumbens dans la motivation et la prise alimentaire
    Roman Walle · 2021 · theses.fr (ABES)
  84. Etude des lipides membranaires comme facteur de vulnérabilité à la psychose chez des patients à ultra haut risque de psychose (UHR) et dans un modèle murin
    Ariel Frajerman · 2021 · theses.fr (ABES)
  85. Social and Role Functioning in the Psychosis Risk Syndrome: Moving Beyond Symptoms for Predicting Psychosis Onset
    Ricardo E. Carrión, Andrea M. Auther, Danielle McLaughlin, Mitchell D. Arnovitz, Jean Addington, Carrie E. Bearden, Kristin S. Cadenhead, Tyrone D. Cannon, Matcheri S. Keshavan, Daniel H. Mathalon et al. · 2025 · Schizophrenia Bulletin
  86. Effects of Nutrition on the Mental Health of Children and Adolescents
    Vinh-Son Nguyen, Barrington Hwang, Shankar Nandakumar · 2026 · Psychiatric Clinics of North America